Less Invasive Acute Rejection Surveillance After Pediatric Heart Transplantation: Experiences From a Low-intensity Biopsy Center
- PMID: 41859287
- PMCID: PMC12999153
- DOI: 10.1097/TXD.0000000000001920
Less Invasive Acute Rejection Surveillance After Pediatric Heart Transplantation: Experiences From a Low-intensity Biopsy Center
Abstract
Background: Acute rejection remains a leading cause of morbidity and mortality early after pediatric heart transplantation (HT). Current guidelines recommend only endomyocardial biopsies (EMB) as reliable for rejection surveillance. We purposed to explore clinical outcomes of less invasive rejection surveillance in a low-intensity biopsy center in pediatric heart recipients.
Methods: We retrospectively analyzed data from 46 pediatric heart recipients (median age 5.7 y; interquartile range [IQR], 2.5-8.0) discharged between 2011 and 2021. Clinical and echocardiographic evaluations were performed frequently, whereas protocol-based routine EMB were scheduled only at 1 and 2 y post-HT. Additional biopsies were performed if new-onset symptoms and/or a decline in graft function, as assessed by echocardiography, including tissue Doppler imaging (TDI)-derived velocities, were detected.
Results: Graft survival was not compromised by less invasive surveillance with 97.8% at 1 y and 95.7% at 2 y post-HT. A total of 680 echocardiograms (median 15 per recipient; IQR, 13-17) and 140 biopsies (median 3 per recipient; IQR, 2-4) were analyzed. Acute rejection (4 acute cellular rejection and 8 antibody-mediated rejection) was found in 8.5% of the EMB. None of the protocol-based routine EMB of asymptomatic patients revealed rejection. Absence of a reduction in TDI-derived left ventricular and interventricular septal systolic velocities, combined with clinical evaluation, correlated with nonrejection.
Conclusions: Combining frequent clinical follow-up with echocardiographic assessment using TDI as a less invasive method of rejection surveillance did not compromise long-term clinical outcomes. Validated in larger pediatric cohorts, it could save invasive biopsies, reducing the risk of biopsy-related complications and medical costs.
Copyright © 2026 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Rossano JW, Singh TP, Cherikh WS, et al. ; International Society for Heart and Lung Transplantation. The International Thoracic Organ Transplant registry of the International Society for Heart and Lung Transplantation: twenty-second pediatric heart transplantation report—2019; focus theme: donor and recipient size match. J Heart Lung Transplant. 2019;38:1028–1041. - PMC - PubMed
-
- Power A, Baez Hernandez N, Dipchand AI. Rejection surveillance in pediatric heart transplant recipients: Critical reflection on the role of frequent and long-term routine surveillance endomyocardial biopsies and comprehensive review of non-invasive rejection screening tools. Pediatr Transplant. 2022;26:e14214. doi:10.1111/petr.14214. - PubMed
-
- Rossano JW, Dipchand AI, Edwards LB, et al. ; International Society for Heart and Lung Transplantation. The registry of the International Society for Heart and Lung Transplantation: nineteenth pediatric heart transplantation report—2016; focus theme: primary diagnostic indications for transplant. J Heart Lung Transplant. 2016;35:1185–1195. - PubMed
-
- Rossano JW, Cherikh WS, Chambers DC, et al. ; International Society for Heart and Lung Transplantation. The registry of the International Society for Heart and Lung Transplantation: twentieth pediatric heart transplantation report—2017; focus theme: allograft ischemic time. J Heart Lung Transplant. 2017;36:1060–1069. - PubMed
LinkOut - more resources
Full Text Sources
